ciprofloxacin has been researched along with Adenocarcinoma in 9 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We therefore investigated the ability of difloxacin, a quinolone antimicrobial antibiotic, to increase drug cytotoxicity in unselected cultured human neuroblastoma cells." | 7.71 | Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin. ( Gilbert, J; Haber, M; Madafiglio, J; Marshall, GM; Norris, MD, 2001) |
| "We therefore investigated the ability of difloxacin, a quinolone antimicrobial antibiotic, to increase drug cytotoxicity in unselected cultured human neuroblastoma cells." | 3.71 | Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin. ( Gilbert, J; Haber, M; Madafiglio, J; Marshall, GM; Norris, MD, 2001) |
| " sordellii ischio-rectal abscess with rapidly fatal septicaemia is described which complicated ultrasound-guided transrectal biopsy of the prostate, despite ciprofloxacin prophylaxis." | 3.70 | Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. ( Borer, A; Buskila, D; Gilad, J; Riesenberg, K; Schlaeffer, F; Sikuler, E, 1999) |
| "In most of the patients studied, ambulatory conservative management was safe and effective in the treatment of uncomplicated acute diverticulitis." | 2.74 | [Safety and efficiency of ambulatory treatment of acute diverticulitis]. ( García Marín, A; Martín Gil, J; Pérez Díaz, MD; Rey Valcárcel, C; Sanz Sánchez, M; Serralta De Colsa, D; Turégano Fuentes, F; Vaquero Rodríguez, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bykowska, A | 1 |
| Komarnicka, UK | 1 |
| Jeżowska-Bojczuk, M | 1 |
| Kyzioł, A | 1 |
| Elshal, AM | 1 |
| Atwa, AM | 1 |
| El-Nahas, AR | 1 |
| El-Ghar, MA | 1 |
| Gaber, A | 1 |
| Elsawy, E | 1 |
| Hashem, A | 1 |
| Farag, Y | 1 |
| Farg, H | 1 |
| Elsorougy, A | 1 |
| Fouda, M | 1 |
| Nabeeh, H | 1 |
| Mosbah, A | 1 |
| Wahl, RU | 1 |
| Megahed, M | 1 |
| Martín Gil, J | 1 |
| Serralta De Colsa, D | 1 |
| García Marín, A | 1 |
| Vaquero Rodríguez, A | 1 |
| Rey Valcárcel, C | 1 |
| Pérez Díaz, MD | 1 |
| Sanz Sánchez, M | 1 |
| Turégano Fuentes, F | 1 |
| Shi, ZY | 1 |
| Li, YQ | 1 |
| Kang, YH | 1 |
| Hu, GQ | 1 |
| Huang-fu, CS | 1 |
| Deng, JB | 1 |
| Liu, B | 1 |
| Pishvaian, AC | 1 |
| Collins, B | 1 |
| Gagnon, G | 1 |
| Ahlawat, S | 1 |
| Haddad, NG | 1 |
| Vaessen, C | 1 |
| Janssen, T | 1 |
| Schulman, C | 1 |
| Borer, A | 1 |
| Gilad, J | 1 |
| Sikuler, E | 1 |
| Riesenberg, K | 1 |
| Schlaeffer, F | 1 |
| Buskila, D | 1 |
| Norris, MD | 1 |
| Madafiglio, J | 1 |
| Gilbert, J | 1 |
| Marshall, GM | 1 |
| Haber, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Multicentric Controlled Clinical Trial of Parallel Groups to Evaluate the Non-therapeutic Inferiority of a Free Diet With a Progressive Diet, in the Treatment of Non-complicated Acute Diverticulitis[NCT03496090] | 134 participants (Actual) | Interventional | 2018-04-16 | Completed | |||
| Comparison of Traditional Back-loaded Fiducial Needles With Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement for Image-guided Radiation Therapy in Patients With Pancreatic Cancer: A Multicenter Randomized Controlled Trial.[NCT02332863] | 44 participants (Actual) | Interventional | 2016-08-03 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of fiducials placed will be recorded during the procedure using a case report form (CRF) for Fiducial Placement Data (NCT02332863)
Timeframe: During scheduled procedure (about 90 minutes)
| Intervention | fiducials (Median) |
|---|---|
| Back-loaded Needle | 3 |
| Preloaded Needle | 3 |
Whether inadvertent deployment of fiducials occurs will be recorded on a CRF for Data Acquisition (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)
| Intervention | Participants (Count of Participants) |
|---|---|
| Back-loaded Needle | 1 |
| Preloaded Needle | 1 |
EUS needle visualization during the procedure will be recorded on a CRF for Scale of Technical Success. (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)
| Intervention | Participants (Count of Participants) |
|---|---|
| Back-loaded Needle | 16 |
| Preloaded Needle | 14 |
Fiducial location on CT scan will be assessed at patient's radiation oncology appointments for IGRT. (NCT02332863)
Timeframe: Several hours to 7 days after fiducial marker deployment
| Intervention | Participants (Count of Participants) |
|---|---|
| Back-loaded Needle | 20 |
| Preloaded Needle | 19 |
Duration of procedure for placing fiducial markers including: Fiducial package was opened start time (start stop watch) + Fiducial placement end time (end stop watch) = Placing Fiducial Markers Time (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)
| Intervention | mintues (Median) |
|---|---|
| Back-loaded Needle | 16 |
| Preloaded Needle | 9 |
Defined as the proper placement of 3 fiducial markers in a pancreatic neoplasm in 2 different planes (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)
| Intervention | Participants (Count of Participants) |
|---|---|
| Back-loaded Needle | 22 |
| Preloaded Needle | 20 |
Total procedure time will be recorded during the procedure using a case report form (CRF) for Procedure Time (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)
| Intervention | minutes (Median) |
|---|---|
| Back-loaded Needle | 27 |
| Preloaded Needle | 25 |
2 trials available for ciprofloxacin and Adenocarcinoma
| Article | Year |
|---|---|
Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Large-Core Needle; Bloo | 2018 |
[Safety and efficiency of ambulatory treatment of acute diverticulitis].
Topics: Abdominal Pain; Abscess; Acute Disease; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory C | 2009 |
7 other studies available for ciprofloxacin and Adenocarcinoma
| Article | Year |
|---|---|
Cu
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt | 2018 |
[Erlotinib-induced acneiform eruption].
Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciproflo | 2013 |
Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell | 2012 |
EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies.
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prop | 2006 |
[Transrectal prostatic biopsy: the role of preventive measures].
Topics: Adenocarcinoma; Anti-Infective Agents; Antibiotic Prophylaxis; Anticoagulants; Bacterial Infections; | 1997 |
Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy.
Topics: Abscess; Adenocarcinoma; Aged; Ampicillin; Anti-Infective Agents; Bacteremia; Biopsy; Ciprofloxacin; | 1999 |
Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin.
Topics: Adenocarcinoma; Anti-Infective Agents; Antimony Potassium Tartrate; ATP-Binding Cassette Transporter | 2001 |